Deutsche Bank Aktiengese... (NYSE:DB)
Historical Stock Chart
3 Months : From Jan 2020 to Apr 2020
Deutsche Bank announced today its appointment as successor depositary bank for the sponsored American Depositary Receipt Program of AstraZeneca PLC (NYSE: AZN).
AstraZeneca is a global, science-led biopharmaceutical company focusing on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in the therapy areas of Oncology, Cardiovascular, Renal and Metabolism, and Respiratory. AstraZeneca operates in more than 100 countries.*
“We are pleased to have been appointed as successor depositary bank for the AstraZeneca PLC American Depositary Receipt program, which is one of the largest and most liquid in the world,” said Daniel Clark, Global Head of Depositary Receipts at Deutsche Bank. “We look forward to providing our dedicated resources and expertise to drive the program’s future success.”
In addition to specializing in administering cross-border equity structures such as New York Shares and American and Global Depositary Receipts, Deutsche Bank provides corporates, financial institutions, hedge funds and supranational agencies around the world with trustee, agency, escrow and related services. Deutsche Bank offers a very broad range of services for diverse products, from complex securitizations and project finance to syndicated loans, debt exchanges and restructurings.
* This information was provided by AstraZeneca PLC (February 2020).
Depositary Receipt Information
Deutsche Bank AG, London Branch
February 6, 2020
Level II ADR
1 ADS : 0.5 Ordinary Shares
Depositary Receipt Contacts
Head of Depositary
Tel: + 44 (20) 754-16888
Tel: +44 (20) 754-77974
Tel: +44 (0) 20 7547 6500
Tel: +1 212 250 9100
Tel: +852 2203 7854
Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany’s leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific.
The Depositary Receipts have been registered pursuant to the US Securities Act of 1933 (the "Act"). The investment or investment service which is the subject of this notice is not available to retail clients as defined by the UK Financial Conduct Authority. This notice has been approved and/or communicated by Deutsche Bank AG New York. The services described in this notice are provided by Deutsche Bank Trust Company Americas (Deutsche Bank) or by its subsidiaries and/or affiliates in accordance with appropriate local registration and regulation. Deutsche Bank is providing the attached notice strictly for information purposes and makes no claims or statement, nor does it warrant or in any way represent, as to the accuracy or completeness of the details contained herein or therein. This announcement appears as a matter of record only. Neither this announcement nor the information contained herein constitutes an offer or solicitation by Deutsche Bank or any other issuer or entity for the purchase or sale of any securities nor does it constitute a solicitation to any person in any jurisdiction where solicitation would be unlawful. No part of this notice may be copied or reproduced in any way without the prior written consent of Deutsche Bank. Past results are not an indication of future performance. Copyright© February 2020 Deutsche Bank AG. All rights reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200206005986/en/
Deutsche Bank AG
Press & Media Relations
Phone: +1 212 250-4875